SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-14-031760
Filing Date
2014-08-11
Accepted
2014-08-11 16:19:35
Documents
9
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 BIOSPECIFICS TECHNOLOGIES CORP 10-Q 6-30-2014 form10q.htm 10-Q 477736
2 EXHIBIT 31 ex31.htm EX-31 10788
3 EXHIBIT 32 ex32.htm EX-32 5363
  Complete submission text file 0001140361-14-031760.txt   2989834

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT bstc-20140630.xml EX-101.INS 312849
5 XBRL TAXONOMY EXTENSION SCHEMA bstc-20140630.xsd EX-101.SCH 24684
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bstc-20140630_cal.xml EX-101.CAL 37744
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bstc-20140630_def.xml EX-101.DEF 67870
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstc-20140630_lab.xml EX-101.LAB 319605
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstc-20140630_pre.xml EX-101.PRE 181237
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34236 | Film No.: 141030791
SIC: 2834 Pharmaceutical Preparations